Entrectinib in Two Pediatric Patients With Inflammatory Myofibroblastic Tumors Harboring ROS1 or ALK Gene Fusions

JCO Precis Oncol. 2018:2:PO.18.00095. doi: 10.1200/PO.18.00095. Epub 2018 Sep 13.

¹ Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Ignyta, Inc., San Diego, CA, USA.

^# Contributed equally.

No abstract available

Keywords: ALK; ROS1; entrectinib; gene fusion; gene rearrangement; inflammatory myofibroblastic tumor.

Grants and funding